Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cardio Diagnostics Holdings (CDIOW) EPS (Basic) (2021 - 2025)

Historic EPS (Basic) for Cardio Diagnostics Holdings (CDIOW) over the last 5 years, with Q3 2025 value amounting to -$0.98.

  • Cardio Diagnostics Holdings' EPS (Basic) rose 4335.26% to -$0.98 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.84, marking a year-over-year increase of 16232.66%. This contributed to the annual value of -$0.31 for FY2024, which is 5279.33% up from last year.
  • Cardio Diagnostics Holdings' EPS (Basic) amounted to -$0.98 in Q3 2025, which was up 4335.26% from -$0.97 recorded in Q2 2025.
  • Cardio Diagnostics Holdings' EPS (Basic)'s 5-year high stood at -$0.06 during Q4 2024, with a 5-year trough of -$5.93 in Q1 2024.
  • Moreover, its 5-year median value for EPS (Basic) was -$0.28 (2022), whereas its average is -$0.9.
  • Per our database at Business Quant, Cardio Diagnostics Holdings' EPS (Basic) surged by 8578.34% in 2023 and then plummeted by 538264.31% in 2024.
  • Quarter analysis of 5 years shows Cardio Diagnostics Holdings' EPS (Basic) stood at -$0.12 in 2021, then tumbled by 518.55% to -$0.77 in 2022, then surged by 85.78% to -$0.11 in 2023, then soared by 48.4% to -$0.06 in 2024, then tumbled by 1634.66% to -$0.98 in 2025.
  • Its last three reported values are -$0.98 in Q3 2025, -$0.97 for Q2 2025, and -$0.97 during Q1 2025.